Achieve life sciences inc - qtrly diluted net loss per share $0.45

Achieve reports financial results for third quarter 2019 and provides update on cytisinicline development program.achieve life sciences inc - qtrly diluted net loss per share $0.45.

ACHV Ratings Summary

ACHV Quant Ranking